Sanofi
- SEC CIK
- 0001121404
- Latest filing
- Jul 28, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 14, 2025. Long positions only.
- Positions
- 9
- No filing for Q3 2024
- Portfolio value
- $174.4M
- No filing for Q3 2024
Sanofi did not file a 13F for Q3 2024, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MGTXMeiraGTx Holdings plc | COM | 12,197,737 | $74.3M | 42.6% | – | – | History |
| NVAXNovavax Inc | COM NEW | 6,880,481 | $55.3M | 31.7% | – | – | History |
| INBXInhibrx Biosciences, Inc. | COM | 1,157,926 | $17.8M | 10.2% | – | – | History |
| ANABAnaptysbio, Inc | COM | 821,917 | $10.9M | 6.2% | – | – | History |
| IGMSIGM Biosciences, Inc. | COM | 1,438,975 | $8.79M | 5.0% | – | – | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 814,980 | $3.36M | 1.9% | – | – | History |
| LVTXLAVA Therapeutics NV | SHS | 1,919,455 | $1.83M | 1.0% | – | – | History |
| INZYInozyme Pharma, Inc. | COM | 443,255 | $1.23M | 0.7% | – | – | History |
| QTTBQ32 Bio Inc. | COM | 244,083 | $839.6K | 0.5% | – | – | History |